Grade 4 Malignant Glioma
1 clinical trials · Condition
◉ Watch Grade 4 Malignant Glioma
| Record | Firm | Date |
|---|---|---|
| Bevacizumab Beyond Progression (BBP) (NCT01740258) | Duke University | 2013-01-01 |
Track Grade 4 Malignant Glioma automatically
Every clearance here is in the API, with alerts when new ones post.